Summary:

- The article discusses the growing policy shifts and concerns around the mRNA vaccine platform, particularly in light of emerging safety data and questions about the long-term effects.
- It highlights the increasing pushback and policy changes in various countries, including the suspension of mRNA vaccines for certain age groups and the reconsideration of vaccine mandates.
- The article suggests that these policy shifts reflect a growing acknowledgment of the potential risks and uncertainties associated with the mRNA technology, and a need for a more cautious and evidence-based approach to its deployment.